INFU (InfuSystems Holdings) ROCE %: 8.26% (As of Mar. 2026)

What is InfuSystems Holdings ROCE %?

InfuSystems Holdings INFU +0.77% 88 ROCE % is 8.26% as of Mar. 2026. GuruFocus rates INFU with a GF Score™ of 88/100 and a GF Value™ of $9.44 (Fairly Valued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. InfuSystems Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 8.26%.

InfuSystems Holdings (AMEX:INFU) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

InfuSystems Holdings ROCE % Related Terms

InfuSystems Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for InfuSystems Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InfuSystems Holdings ROCE % Chart

InfuSystems Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

3.32

1.81

4.67

7.90

14.34

InfuSystems Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															2.70	17.63	18.20	18.72	8.26

88GF Score

InfuSystems Holdings Inc INFU

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

InfuSystems Holdings ROCE % Calculation

InfuSystems Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	11.922	/	( ( (103.614 - 17.661)	+	(100.56 - 20.182) )	/ 2 )
	=	11.922	/	( (85.953	+	80.378)	/ 2 )
	=	11.922	/	83.1655
	=	14.34 %

InfuSystems Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	6.688	/	( ( (100.56 - 20.182)	+	(98.657 - 17.142) )	/ 2 )
	=	6.688	/	( ( 80.378	+	81.515 )	/ 2 )
	=	6.688	/	80.9465
	=	8.26 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 8.26% mean?

InfuSystems Holdings (INFU) has a ROCE % of 8.26% as of Mar. 2026.

Is InfuSystems Holdings' ROCE % too high?

InfuSystems Holdings' current ROCE % is 8.26%. The Medical Devices & Instruments industry median ROCE % is 2.23. InfuSystems Holdings' value of 8.26% is 270.4% above this industry median. Overall, InfuSystems Holdings has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does InfuSystems Holdings' ROCE % compare to TANAF and INGN?

InfuSystems Holdings' ROCE % of 8.26% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. InfuSystems Holdings' value of 8.26% is 270.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current ROCE % of 8.26% is 270.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current ROCE % is 8.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is InfuSystems Holdings stock overvalued right now?

Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $9.15 — trading 3.1% below its estimated fair value. The current ROCE % is 8.26% and 270.4% above the Medical Devices & Instruments industry median of 2.23. InfuSystems Holdings' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current ROCE % is 8.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InfuSystems Holdings (INFU) Overvalued in 2026?

Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be undervalued. The current stock price of $9.15 is trading 3.1% below its estimated GF Value™ of $9.44. GuruFocus considers InfuSystems Holdings to be Fairly Valued.

Key valuation signals for INFU:

ROCE %: 8.26%
GF Value™: $9.44 vs. price of $9.15 (3.1% below fair value)
GF Score™: 88/100 with 2 warning signs
Industry Position: 270.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InfuSystems Holdings Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TANAF INGN LUCD APYX OWLT TLSI HYPR CVRX RXST QTRX ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges 1TZ:Germany

Address 3851 West Hamlin Road, Rochester Hills, MI, USA, 48309

Website http://www.infusystem.com

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.

88GF Score

Get the complete analysis for INFU

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.15

Price

$9.44

GF Value

View INFU Analysis

See ROCE % data for all stocks →